The Fenway Institute, Fenway Community Health, Boston, MA 02215, United States.
Drug Alcohol Depend. 2010 Jul 1;110(1-2):30-7. doi: 10.1016/j.drugalcdep.2010.01.017. Epub 2010 Mar 23.
Although the association of stimulant use to sexual risk taking and HIV transmission has been well documented among white gay men, stimulant use during sex continues to be under-explored among Black men who have sex with men (MSM).
Black MSM (n=197) recruited via modified respondent-driven sampling between January and July 2008 completed an interviewer-administered quantitative assessment and optional HIV counseling and testing. Bivariate logistic regression procedures were employed to examine the association of demographics, sexual risk, and other psychosocial factors with stimulant use (at least monthly during sex in the past 12 months). Variable elimination using the backward selection process was used to fit two separate final multivariable logistic regression models examining stimulant use as the outcome and HIV sexual risk in the past 12 months by gender as the primary predictor: (1) Model 1: HIV sexual risk behavior with a casual male sex partner as a primary, forced predictor; (2) Model 2: HIV sexual risk behavior with a female sex partner as primary, forced predictor.
One-third (34%) of Black MSM reported using stimulants monthly or more frequently during sex in the past 12 months. The following factors were independently associated with stimulant use during sex: (1) Model 1: unprotected anal sex with a casual male sex partner in the past 12 months (AOR=2.61; 95% CI=1.06-6.42; p=0.01), older age (AOR=1.09; 95% CI=1.05-1.15; p<0.001), erectile dysfunction (ED) medication use monthly or more during sex in the past 12 months (AOR=7.81; 95% CI=1.46-41.68; p=0.02), problematic alcohol use (AOR=3.31; 95% CI=1.312-8.38; p=0.005), and higher HIV treatment optimism (AOR=0.86; 95% CI=0.76-0.97; p=0.01). (2) Model 2: unprotected vaginal or anal sex with a female partner in the past 12 months (AOR=3.54; 95% CI=1.66-7.56; p=0.001), older age (AOR=1.10; 95% CI=1.05-1.14; p<0.001), ED use monthly or more during sex in the past 12 months (AOR=3.70; 95% CI=1.13-12.13; p=0.03), clinically significant depressive symptoms (CES-D) at the time of study enrollment (AOR=3.11; 95% CI=1.45-6.66; p=0.004), and supportive condom use norms (AOR=0.69; 95% CI=0.49-0.97; p=0.03).
Frequent stimulant use is an important factor in HIV and STD sexual risk among Black MSM, particularly for older men and those with co-occurring psychosocial morbidities. HIV and STD prevention interventions in this population may benefit from addressing the precipitants of stimulant use and sexual risk taking.
尽管在白人男同性恋者中,兴奋剂的使用与性风险行为和 HIV 传播之间的关联已得到充分证明,但在与男性发生性关系的黑人男同性恋者中,性活动中使用兴奋剂的情况仍未得到充分探讨。
2008 年 1 月至 7 月期间,通过改良的应答驱动抽样方法招募了黑人男同性恋者(n=197),他们完成了访谈者管理的定量评估和可选的 HIV 咨询和检测。采用双变量逻辑回归程序来检查人口统计学、性风险和其他社会心理因素与兴奋剂使用(过去 12 个月中至少每月一次性活动中使用兴奋剂)之间的关联。使用后向选择过程进行变量消除,以拟合两个单独的最终多变量逻辑回归模型,分别以过去 12 个月中 HIV 性风险行为(以过去 12 个月中与偶然男性性伴侣发生的 HIV 性风险行为作为主要预测因素)和性别(以过去 12 个月中与女性性伴侣发生的 HIV 性风险行为作为主要预测因素)为结果:(1)模型 1:以偶然男性性伴侣为主要、强制预测因素的 HIV 性风险行为;(2)模型 2:以女性性伴侣为主要、强制预测因素的 HIV 性风险行为。
三分之一(34%)的黑人男同性恋者报告过去 12 个月中每月或更频繁地在性活动中使用兴奋剂。以下因素与性活动中使用兴奋剂独立相关:(1)模型 1:过去 12 个月中与偶然男性性伴侣发生无保护的肛交性行为(AOR=2.61;95%CI=1.06-6.42;p=0.01),年龄较大(AOR=1.09;95%CI=1.05-1.15;p<0.001),过去 12 个月中每月或更频繁地使用勃起功能障碍(ED)药物治疗(AOR=7.81;95%CI=1.46-41.68;p=0.02),有问题的酒精使用(AOR=3.31;95%CI=1.312-8.38;p=0.005),以及较高的 HIV 治疗乐观态度(AOR=0.86;95%CI=0.76-0.97;p=0.01)。(2)模型 2:过去 12 个月中与女性伴侣发生无保护的阴道或肛门性交(AOR=3.54;95%CI=1.66-7.56;p=0.001),年龄较大(AOR=1.10;95%CI=1.05-1.14;p<0.001),过去 12 个月中每月或更频繁地使用 ED 药物治疗(AOR=3.70;95%CI=1.13-12.13;p=0.03),研究入组时出现临床显著抑郁症状(CES-D)(AOR=3.11;95%CI=1.45-6.66;p=0.004),以及支持避孕套使用规范(AOR=0.69;95%CI=0.49-0.97;p=0.03)。
在黑人男同性恋者中,频繁使用兴奋剂是 HIV 和性传播疾病(STD)性风险的一个重要因素,特别是对于年龄较大和同时存在社会心理障碍的男性。在这一人群中,HIV 和 STD 预防干预措施可能受益于解决兴奋剂使用和性冒险行为的诱因。